{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:30:07Z","timestamp":1786437007804,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,16]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Sugammadex sodium can antagonize aminosteroidal muscarinic drugs precisely and rapidly, so it has been widely used in fast-track anesthesia in recent years. However, it is not known whether there is an advantage of the antagonistic effect of sugammadex sodium over neostigmine at different doses and time points. In this single-center, randomized controlled study, we compared the effects of sugammadex sodium with neostigmine on postoperative myorelaxation recovery in patients undergoing suspension laryngoscopic surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A total of 90 patients scheduled for elective general anesthesia suspension laryngoscopy were selected, aged 18 to 65 years, body mass index 18 to 28\u2009kg\/m\u00b2, and American Society of Anesthesiologists I\u2013II grade. Patients were randomly divided into 3 groups: the sugammadex group (experimental groups, S\n                      <jats:sub>1<\/jats:sub>\n                      , S\n                      <jats:sub>2<\/jats:sub>\n                      ), and the neostigmine group (control group, N), each comprising 30 patients. After the operation, group S\n                      <jats:sub>1<\/jats:sub>\n                      received an intravenous injection of sugammadex sodium 2\u2009mg\/kg immediately, S\n                      <jats:sub>2<\/jats:sub>\n                      received it when train-of-four COUNT (TOF-COUNT)\u2005&gt;\u20052, and group N received intravenous injections of atropine 0.02\u2009mg\/kg\u2005+\u2005neostigmine 0.04\u2009mg\/kg when TOF-COUNT\u2005&gt;\u20052. The mean arterial pressure, heart rate, pulse oxygen saturation, and bispectral index were recorded at various times: upon room entry (T\n                      <jats:sub>1<\/jats:sub>\n                      ), during tracheal intubation (T\n                      <jats:sub>2<\/jats:sub>\n                      ), at surgery start (T\n                      <jats:sub>3<\/jats:sub>\n                      ), surgery end (T\n                      <jats:sub>4<\/jats:sub>\n                      ), at extubation (T\n                      <jats:sub>5<\/jats:sub>\n                      ), and upon room exit (T\n                      <jats:sub>6<\/jats:sub>\n                      ). The duration of surgery, muscle relaxation recovery time from TOF-COUNT 0-2 at surgery end, and time from surgery end to extubation were recorded for each group, as well as the incidence of adverse reactions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were no statistically significant differences among the 3 groups in mean arterial pressure, heart rate, pulse oxygen saturation, and bispectral index at the 6 time points (T\n                      <jats:sub>1<\/jats:sub>\n                      , T\n                      <jats:sub>2<\/jats:sub>\n                      , T\n                      <jats:sub>3<\/jats:sub>\n                      , T\n                      <jats:sub>4<\/jats:sub>\n                      , T\n                      <jats:sub>5<\/jats:sub>\n                      , and T\n                      <jats:sub>6<\/jats:sub>\n                      ). In terms of extubation timing, the S\n                      <jats:sub>1<\/jats:sub>\n                      group showed a significantly shorter time compared with the S\n                      <jats:sub>2<\/jats:sub>\n                      and N groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Compared with the S\n                      <jats:sub>2<\/jats:sub>\n                      group, N group had significantly prolonged extubation times, showing a statistical difference. Compared with the N group, S\n                      <jats:sub>1<\/jats:sub>\n                      and S\n                      <jats:sub>2<\/jats:sub>\n                      groups had a significantly reduced incidence of bradycardia and increased secretions (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The use of sugammadex sodium in otolaryngological suspension laryngoscopy surgeries offers certain advantages over neostigmine in terms of muscle relaxation recovery. Administering sugammadex sodium 2\u2009mg\/kg directly after surgery as compared with waiting until TOF-COUNT\u2005&gt;\u20052 allows for earlier removal of the tracheal tube without increasing adverse reactions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000042385","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:00:48Z","timestamp":1747836048000},"page":"e42385","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The effect of sugammadex sodium on muscle relaxation recovery in patients after suspension laryngoscopy surgery: A randomized controlled trial"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9684-6031","authenticated-orcid":false,"given":"Qian","family":"Ge","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, The Third People\u2019s Hospital of Dalian, Dalian, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Third People\u2019s Hospital of Dalian, Dalian, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5591-1723","authenticated-orcid":false,"given":"Shiling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Third People\u2019s Hospital of Dalian, Dalian, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260811","first-page":"71","article-title":"Effect analysis of ultrasound-guided fast channel anesthesia in short ear, nose and throat surgery.","volume":"37","author":"Zhang","year":"2022","journal-title":"Chin Med Digest (Otorhinolaryngology)"},{"key":"R2-20260811","first-page":"1154","article-title":"Clinical efficacy of nasal endoscopy combined with supported laryngoscope in the treatment of vocal cord polyps and its effect on voice function.","volume":"34","author":"Sun","year":"2021","journal-title":"J Math Med"},{"key":"R3-20260811","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1213\/ANE.0000000000004305","article-title":"Sugammadex administration in pregnant women and in women of reproductive potential: a narrative review.","volume":"130","author":"Richardson","year":"2020","journal-title":"Anesth Analg"},{"key":"R5-20260811","first-page":"65","article-title":"Clinical effect of nasal endoscopy combined with supported laryngoscopy in the treatment of benign glottic masses.","volume":"9","author":"Liu","year":"2023","journal-title":"World J Complex Med"},{"key":"R6-20260811","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12871-023-02309-4","article-title":"Correction: rate of residual neuromuscular block using single\u2011dose rocuronium in general anesthesia for ENT surgery: a retrospective cohort study.","volume":"23","author":"Carrillo-Torres","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"R7-20260811","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/ph15070894","article-title":"Analgesic and anesthetic efficacy of rocuronium\/sugammadex in otorhinolaryngologic surgery: a propensity score-matched analysis.","volume":"15","author":"Wu","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"R8-20260811","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13741-021-00203-6","article-title":"Influence of sugammadex versus neostigmine for neuromuscular block reversal on the incidence of postoperative pulmonary complications: a meta-analysis of randomized controlled trials.","volume":"10","author":"Wang","year":"2021","journal-title":"Perioper Med (Lond)"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12871-018-0605-6","article-title":"Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.","volume":"18","author":"De Boer","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"R10-20260811","first-page":"599","article-title":"Sugammadex versus neostigmine for routine reversal of neuromuscular blockade and the effect on perioperative efficiency.","volume":"35","author":"Moss","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R11-20260811","doi-asserted-by":"crossref","first-page":"12566","DOI":"10.21037\/apm-21-3398","article-title":"Sugammadex enhances recovery after abdominal surgery in cancer patients: a real-world, observational study.","volume":"10","author":"Gu","year":"2021","journal-title":"Ann Palliat Med"},{"key":"R13-20260811","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-022-03922-4","article-title":"Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis.","volume":"26","author":"He","year":"2022","journal-title":"Crit Care"},{"key":"R14-20260811","doi-asserted-by":"crossref","first-page":"e26796","DOI":"10.1097\/MD.0000000000026796","article-title":"Sugammadex induced bradycardia and hypotension: a case report and literature review.","volume":"100","author":"Teng","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R15-20260811","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/medicina57010079","article-title":"Severe hypotension, bradycardia and asystole after sugammadex administration in an elderly patient.","volume":"57","author":"Fierro","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R16-20260811","first-page":"4044","article-title":"Research progress in the evaluation of sodium suggenose for allergic reactions to rocuronium bromide.","volume":"37","author":"Huo","year":"2021","journal-title":"J Modern Med Health"},{"key":"R17-20260811","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/joacp.JOACP_573_20","article-title":"Sugammadex-induced anaphylactic reaction: a systematic review.","volume":"38","author":"Zecic","year":"2022","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"R18-20260811","first-page":"622","article-title":"Different doses of sugamose sodium reversed the effect of rocuronium neuromuscular block.","volume":"38","author":"Wang","year":"2022","journal-title":"J Pract Med"},{"key":"R19-20260811","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.jfma.2022.04.017","article-title":"Sugammadex reversal of muscle relaxant blockade provided less post-anesthesia care unit adverse effects than neostigmine\/glycopyrrolate.","volume":"121","author":"Chang","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"R20-20260811","doi-asserted-by":"crossref","first-page":"905131","DOI":"10.3389\/fmed.2022.905131","article-title":"Effects of sugammadex and neostigmine on post-operative nausea and vomiting in ENT surgery.","volume":"9","author":"Mat","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R21-20260811","doi-asserted-by":"crossref","first-page":"191","DOI":"10.17085\/apm.21096","article-title":"Adverse events of sugammadex that occurred in a Korean population.","volume":"17","author":"Han","year":"2022","journal-title":"Anesth Pain Med (Seoul)"},{"key":"R22-20260811","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4097\/kja.19344","article-title":"Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex \u2013 a case report.","volume":"73","author":"Choi","year":"2020","journal-title":"Korean J Anesthesiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:00:37Z","timestamp":1786435237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":20,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042385","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}